Nika Pharmaceuticals Inc. (NIKA)
Nika Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Henderson, NV, US. The stock last traded at $0.42, down 17.65% on the session, giving a market capitalisation of $440.4M. On trailing twelve-month figures it carries a trailing P/E of -5653.75, a net margin of 0.0%. Its beta of -2.48 implies it has historically moved less than the broad market.
Nika Pharmaceuticals Inc., a pharmaceutical enterprise headquartered in Henderson, Nevada, focuses on the creation of medications to address a broad spectrum of health conditions. Its research and development efforts target serious diseases including HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, and diabetes. The company's product line features antiviral treatments and nutritional supplements, notably providing a specialized thymus nuclear glycoprotein for the management of HIV. Originally established in 2000, the organization was previously known as Centennial Growth Equities Inc. before adopting its current name, Nika Pharmaceuticals, Inc., in May 2022.
Nika Pharmaceuticals Inc. is most often compared with the following Healthcare names: